A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.Shigeji Matsubara, Leland W.K. Chung, Haiyen E. Zhau et al.|PubMed|2001Cited by 149
Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate CancerHiroyuki Kubo, Leland W.K. Chung, Thomas A. Gardner et al.|Human Gene Therapy|2003Cited by 127
Osteocalcin-directed gene therapy for prostate-cancer bone metastasisKenneth S. Koeneman, Thomas A. Gardner, Leland W.K. Chung et al.|World Journal of Urology|2000Cited by 121